TYPE 2 DIABETES MELLITUS – AN AUTOIMMUNE DISEASE?

Author:

Asfandiyarova N. S.

Abstract

In recent years, the association of type 2 diabetes mellitus (DM) to autoimmune diseases has been discussed. Participation of innate immunity in the development of inflammation in obesity and insulin resistance, which determine the development of type 2 DM is well known. These changes, along with gluco- and lipotoxicity, lead to the destruction of the pancreatic β cells, emergence of autoantigens and development both humoral and cell type autoimmune reactions. The effectiveness of drugs used in the treatment of autoimmune diseases also leads some authors to the conclusion that type 2 diabetes can be referred to autoimmune diseases. However, most researchers believe that the presence of an autoimmune component is a side effect of inflammation and do not consider type 2 diabetes as an autoimmune disease.Alternatively, autoimmune reactions may take part in the pathogenesis of type 2 diabetes because: a viral infection contributes to the development of antiviral immunity, however, in the presence of insulin-cross-reactive antigens, an autoimmune reaction is observed. Most patients with uncompromised immune system, the clone of auto-aggressive cells sensitized to insulin is destroyed. In a small percentage of patients with impaired immune system, insulin-sensitized lymphocytes do not die that leads to destruction of pancreatic islet cells and development of type 1 diabetes. In other patients, on the one hand, the immune system is also unable to remove the cell clone exerting signs of autoaggression, but it tries to suppress this effect by blocking insulin receptors on immunocompetent cells. This maneuver succeeds, and suppression is reversible. However, insulin receptors are abundant not only on sensitized lymphocytes, but also on liver cells, muscles, and adipose tissue. The effect of blocking insulin receptors in insulin-sensitive tissues contributes to the development of primary insulin resistance, which precedes and contributes to the development of obesity. Subsequently, excessive intake of dietary fats results in obesity progression, so that the entire cascade of inflammatory reactions is involved in the pathological process. This, in turn, contributes to the formation of secondary insulin resistance, which accounts for the development of type 2 diabetes and cardiovascular diseases and so on.Type 2 diabetes does not belong to autoimmune diseases, but suppressed autoimmune reactions with respect to insulin play a role in the development of insulin resistance.

Publisher

Russian Society of Immunology

Subject

Immunology,General Medicine

Reference53 articles.

1. Асфандиярова Н.С. Гетерогенность сахарного диабета 2 типа: клиническая характеристика 4 подтипов // Терапевтический архив, 2011. Т. 83, № 10. С. 27-31.

2. Асфандиярова Н.С., Низов А.А., Журавлева Н.С., Колдынская Э.И., Гиривенко А.И. Нестероидные противовоспалительные средства в лечении остеоартроза у больных сахарным диабетом 2 типа // Актуальные проблемы гуманитарных и естественных наук, 2013. № 12. С. 330-335.

3. Асфандиярова Н.С., Шатров В.В., Гарипов Г.К. Сенсибилизация лимфоцитов к антигенам вирусов семейства Paramyxoviridae при сахарном диабете // Проблемы эндокринологии, 2006. Т. 52, № 6. С. 18-21.

4. Дедов И.И., Мельниченко Г.А., Фадеев В.В. Эндокринология: учебник. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2014. 442 с.

5. Драенкова Ф.Р., Пустынкина Л.С., Лесовой А.Е. Динамика и тенденции первичной инвалидности взрослого раселения Рязанской области // Наука молодых, 2013. № 4. С. 117-121.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3